D
60
5
A
44
-2
DGX
39
-4
BBY
56
-2
DE
53
8
TXN
50
-3
AMP
66
-4
MU
34
3
SWK
81
-3
L
55
-4
MS
64
7
HOG
50
6
XYL
54
-4
CHK
48
15
HRL
30
-5
MCHP
43
-6
FMC
40
4
ACN
56
13
XRAY
31
-3
UNP
40
-2
D
60
5
A
44
-2
DGX
39
-4
BBY
56
-2
DE
53
8
TXN
50
-3
AMP
66
-4
MU
34
3
SWK
81
-3
L
55
-4
MS
64
7
HOG
50
6
XYL
54
-4
CHK
48
15
HRL
30
-5
MCHP
43
-6
FMC
40
4
ACN
56
13
XRAY
31
-3
UNP
40
-2
Financhill
Back

Akamai Technologies Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
62

AKAM
Akamai Technologies

Last Price:
99.46
Seasonality Move:
19.16%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
62
Akamai Technologies (AKAM) is a Buy

Is Akamai Technologies a Buy, Sell or Hold?

  • The current Akamai Technologies [AKAM] share price is $99.52. The Score for AKAM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • AKAM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AKAM Stock Price Chart

What is Akamai Technologies's stock price today?

  • The Akamai Technologies share price today is $99.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKAM is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

AKAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 53.96 Buy
Chaikin Money Flow: 576058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (97.32 - 101.62) Buy
Bollinger Bands (100): (91.07 - 99.85) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

AKAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 98.26 Buy
20-day SMA: 98.96 Buy
50-day SMA: 97.97 Buy
200-day SMA: 104.37 Sell
8-day EMA: 98.51 Buy
20-day EMA: 98.52 Buy
50-day EMA: 97.81 Buy
200-day EMA: 100.04 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Akamai Technologies Earnings Growth & AKAM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.13 per share, an increase this year of $0.33 per share, and an increase next year of $0.42 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Akamai Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):